Literature DB >> 24050796

Relationship between body mass index and prognosis of patients presenting with potential acute coronary syndromes.

Jon Dooley1, Anna Marie Chang, Rama A Salhi, Judd E Hollander.   

Abstract

OBJECTIVES: Studies examining the relationship between obesity and acute coronary syndrome (ACS) have been limited to patients with confirmed diagnoses. The authors sought to determine the relationship between body mass index (BMI) and 30-day cardiovascular events in emergency department (ED) patients with potential ACS.
METHODS: This was a secondary analysis of a prospective cohort study of patients who presented to the ED with potential ACS. Patients were stratified according to their BMI: underweight (BMI < 18.49 kg/m(2) ), normal weight (BMI = 18.5 to 24.99 kg/m(2) ), overweight (BMI = 25 to 29.99 kg/m(2) ), obese (BMI = 30 to 34.99 kg/m(2) ), and very obese (BMI > 35 kg/m(2) ). The primary outcome was acute myocardial infarction (AMI), death, or revascularization within 30 days of presentation. A logistic regression analysis was used to adjust for confounding variables and adjusted odds ratios (aOR) with 95% confidence intervals (CIs) are presented for cardiac events and readmission outcomes.
RESULTS: Of the 3,946 patients included in this study, 73 (1.9%) were underweight, 911 (23%) were normal weight, 1,199 (30.4%) were overweight, 872 (22.1%) were obese, and 891 (22.6%) were very obese. Although increased levels of obesity were associated with a greater number of cardiac risk factors, there was no difference in 30-day cardiovascular events between those of normal weight and underweight (aOR = 1.1; 95% CI = 0.4 to 2.7), overweight (aOR = 1.0; 95% CI = 0.7 to 1.4), obese (aOR = 1.2; 95% CI = 0.8 to1.7), or very obese (aOR = 0.8; 95% CI = 0.5 to 1.3). Those who were underweight were more likely to be readmitted within 30 days (aOR = 1.9; 95% CI = 1.0 to 3.7), and those who were very obese were less likely to be readmitted within 30 days (aOR = 0.7; 95% CI = 0.5 to 0.9).
CONCLUSIONS: Among patients who present to the ED with potential ACS, BMI is not associated with higher risk of cardiovascular outcomes at 30 days.
© 2013 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Year:  2013        PMID: 24050796      PMCID: PMC3947614          DOI: 10.1111/acem.12211

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  43 in total

1.  Underweight and overweight in relation to mortality among men aged 40-59 and 50-69 years: the Seven Countries Study.

Authors:  T L Visscher; J C Seidell; A Menotti; H Blackburn; A Nissinen; E J Feskens; D Kromhout
Journal:  Am J Epidemiol       Date:  2000-04-01       Impact factor: 4.897

2.  The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI).

Authors:  Hitinder S Gurm; Patrick L Whitlow; Kevin E Kip
Journal:  J Am Coll Cardiol       Date:  2002-03-06       Impact factor: 24.094

3.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

4.  CT angiography for safe discharge of patients with possible acute coronary syndromes.

Authors:  Harold I Litt; Constantine Gatsonis; Brad Snyder; Harjit Singh; Chadwick D Miller; Daniel W Entrikin; James M Leaming; Laurence J Gavin; Charissa B Pacella; Judd E Hollander
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

5.  Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.

Authors:  M Wei; J B Kampert; C E Barlow; M Z Nichaman; L W Gibbons; R S Paffenbarger; S N Blair
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

Review 6.  The epidemiological relationship of hypercholesterolemia, hypertension, diabetes mellitus and obesity to coronary heart disease and atherogenesis.

Authors:  W E Stehbens
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

Review 7.  Chest pain centers: diagnosis of acute coronary syndromes.

Authors:  A B Storrow; W B Gibler
Journal:  Ann Emerg Med       Date:  2000-05       Impact factor: 5.721

8.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:  J S Alpert; K Thygesen; E Antman; J P Bassand
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

9.  Abdominal obesity is associated with increased risk of acute coronary events in men.

Authors:  H-M Lakka; T A Lakka; J Tuomilehto; J T Salonen
Journal:  Eur Heart J       Date:  2002-05       Impact factor: 29.983

10.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

Authors:  Peter W F Wilson; Ralph B D'Agostino; Lisa Sullivan; Helen Parise; William B Kannel
Journal:  Arch Intern Med       Date:  2002-09-09
View more
  3 in total

1.  Obesity, Treatment Times, and Cardiovascular Outcomes After ST-Elevation Myocardial Infarction: Findings From Mission: Lifeline North Texas.

Authors:  Tiffany Champagne-Langabeer; Junghyun Kim; Julie K Bower; Angela Gardner; Raymond Fowler; James R Langabeer
Journal:  J Am Heart Assoc       Date:  2017-09-22       Impact factor: 5.501

2.  Applicability of the masseter muscle as a nutritional biomarker.

Authors:  Yunsup Hwang; Yoon Hyun Lee; Dae Hyun Cho; Maru Kim; Dae-Sang Lee; Hang Joo Cho
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.889

3.  Sex-Specific Impact of Different Obesity/Metabolic Phenotypes on Long-Term Cardiovascular Outcomes in Acute Coronary Syndrome Patients.

Authors:  Egidio Imbalzano; Giuseppina T Russo; Annalisa Giandalia; Angela Sciacqua; Luana Orlando; Vincenzo Russo; Maria Perticone; Arrigo F G Cicero; Antonio Giovanni Versace; Pierpaolo Di Micco; Vincenzo Antonio Ciconte; Giuseppe Dattilo; Giovanni Squadrito; Marco Vatrano
Journal:  Biomedicines       Date:  2022-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.